How to Buy Caribou Biosciences Stock
Caribou Biosciences Inc
Caribou Biosciences, Inc. , a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally.
Caribou Biosciences stock last closed at $0.85, down 0.12% from the previous day, and has decreased 76.56% in one year. It has overperformed other stocks in the Biotechnology industry by 0 percentage points. Caribou Biosciences stock is currently +28.94% from its 52-week low of $0.66, and -78.35% from its 52-week high of $3.93.
As of Apr 30, 2025, there are 93M CRBU shares outstanding. The market cap of CRBU is $79.15M. In the past 24 hours, 785,504 CRBU shares were traded.
How to Buy Caribou Biosciences Stock
Not sure how to invest in Caribou Biosciences stock? Here's how.
- Decide where to buy Caribou Biosciences stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Caribou Biosciences stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Select your method of payment and add your details.
- Research Caribou Biosciences stock: The Caribou Biosciences ticker symbol is CRBU. Is Caribou Biosciences stock a good investment? Should you buy shares of CRBU? How do CRBU's underlying business fundamentals look? Do top analysts think Caribou Biosciences is a good buy? Why has CRBU's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if CRBU is a good stock to buy).
- Make your CRBU buy order: Decide if you will purchase CRBU shares at the current market price or use a limit order to purchase CRBU shares at a particular price.
- Keep an eye on your CRBU investment: Create a watchlist to keep tabs on your new investment in Caribou Biosciences shares.
Step 1: Decide where to buy Caribou Biosciences stock
You will need a brokerage account in order to access the NASDAQ market and buy CRBU stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Utilities, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the best brokerage, you need to fill out some personal details so you are able to invest in CRBU stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create your new trading account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have filled out your info on investing apps, you need to deposit funds:
Watch the tutorial below to see the process of transferring money into your new investment account.
Step 4: Research Caribou Biosciences stock
After you have chosen the best place to buy Caribou Biosciences stock, it's very important to research their stock prior to investing, so you actually comprehend the risk and upside.
Caribou Biosciences Metrics
CRBU Due Diligence Checks
WallStreetZen was created to help everyday investors do more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on CRBU's stock page.
Is CRBU stock properly valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge CRBU's intrinsic value.
Using relative valuations methods:
- CRBU may be undervalued based on its P/B ratio of 0.31x, relative to Biotechnology industry P/B ratio of 4.45x
You can access additional valuation analysis on CRBU's stock here.
How do CRBU Financials look?
Pros:
- CRBU has a low debt to equity ratio of 0.24.
- There are more short-term assets than long-term liabilities on the CRBU balance sheet.
- CRBU has cash burn of 143067000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the CRBU balance sheet.
- Total CRBU debt is lower than 5 years ago, relative to shareholder equity.
Cons:
- CRBU has $209.54M in cash and short term investments. This is not enough to cover its annual cash burn of $143.07M.
- CRBU profit margin has gone down from -296.1% to -1,491.9% in the past year.
Is it a good time to buy Caribou Biosciences stock, according to analysts?
Out of 3 Wall Street analysts who monitor CRBU, the consensus analyst rating on Caribou Biosciences is a Strong Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Caribou Biosciences stock forecast page.
CRBU Technicals
How is CRBU performing as a company?
Last year, CRBU revenue was $9.99M. During the last five year, CRBU's revenue has grown by 11.54% per year. This was slower than the Biotechnology industry average of 45.66%.
Learn more about CRBU's earnings and revenue performance here.
Latest Insiders Trades at CRBU
Over the past year, insiders at CRBU have bought more shares than they have sold.
Rachel E. Haurwitz, President and CEO of CRBU, was the latest CRBU insider to buy. They bought $20,400.00 worth of CRBU stock on Mar 14, 2025.
Learn more about who owns CRBU stock here.
Can I get consistent income from CRBU stock?
No, Caribou Biosciences doesn't provide an income stream by paying out dividends.
What do other traders have to say about CRBU?
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your CRBU buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount, place a limit order.
Press the Open button and your broker will place the order.
If you require more info about buying stocks on eToro, watch the how to video below:
Step 6: Keep an eye on your CRBU investment
Now that you own some CRBU shares, you'll want to stay up-to-date on your investment.
Add CRBU to a watchlist to track your CRBU stock.
CRBU Feed
How to Buy Stock in Caribou Biosciences
To reiterate, here are the 6 steps to buy stock in Caribou Biosciences:
- Decide where to buy Caribou Biosciences stock
- Open your brokerage account
- Deposit money your brokerage account
- Research Caribou Biosciences stock
- Make your CRBU buy order
- Keep an eye on your CRBU investment
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get updates on your investment in Caribou Biosciences, get started below.
Other Content You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.